InvestorsHub Logo

rodman

06/05/15 3:58 PM

#76 RE: Lestatk #75

I am a risk taker for better or WORSE? (Usually buy to high and sell to low) An aquaintenance bot at 2.3 and sold at 6.5 when VNRX ran to $9+ so VNRX certainly move up on a great clinical trial!

http://www.volitionrx.com/news/press-releases/detail/517/volitionrx-accelerates-clinical-trial-with-university

focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions. - See more at: http://win-health.org/volitionrx-early-colorectal-cancer-detection/#sthash.mCV7zlg0.dpuf

I am optimistic!